FAPI PET/CT for Staging New High-Risk Prostate Cancer
Part of Cancer, Kidney & urinary clinical trials.
This study uses a special type of PET/CT scan (FAPI) to see if it can better detect where prostate cancer has spread in men with newly diagnosed, high-risk disease. It may help doctors plan more accurate treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult male (18 years or older).
- You are able to be up and about (not bedridden).
- You have a new diagnosis of prostate cancer confirmed by biopsy.
- Your cancer is considered high-risk (Gleason grade group 3 or higher, PSA 20 or more, or the tumor has spread outside the prostate).
- You have either (a) a PSMA PET/CT that shows cancer spread, or (b) a PSMA PET/CT that shows no spread but you have a high risk of lymph node spread and are scheduled for prostate surgery with lymph node removal.
- You do not have another active cancer that could confuse the scan results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of imaging scan called 68Ga-FAPI-PSMA PET that may help doctors better detect and diagnose solid tumors like prostate, liver, ovarian, or endometrial cancer. You would receive the scan before having a biopsy or surgery.
This trial studies how a special PET/CT scan (using 18F-DCFPyL) helps evaluate prostate cancer that is either high-risk at diagnosis or has come back based on PSA blood tests. It may help your care team better stage (map) the cancer and guide next steps.
This Phase 3 study checks whether a PSMA PET/CT scan (using a special tracer) can help doctors make better decisions for people with prostate cancer after treatment, based on PSA blood test changes. It may help identify whether cancer has spread or how to plan next steps.
This trial uses a new type of PET/MRI scan (called FAPI) to see how well it can find prostate cancer. It may help doctors learn about a different way to image the cancer. You can join if you already have a scheduled or recent PSMA PET scan.
This study uses a special PET scan (FAPI-PET) during routine workup to help detect tumors and decide how far they may have spread. You may be able to take part if you need a staging or restaging scan and can safely complete the imaging.
This study tests a new type of PET scan that uses a special tracer called FAPI to find where cancer has spread in your body. It may help doctors see hidden tumors more clearly without needing extra treatments first.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.